Viewing 0 reply threads
  • Author
    Posts
    • #18895
      John Connor
      Keymaster

      A new study has found  people with MS tend to have lower levels of infection-fighting antibodies, whether they are using disease modifying drugs or not.

      The levels were found to be lower across all MS subtypes, but particularly so in people with secondary progressive MS.

      OK this is a mouthful: The research was published in Therapeutic Advances in Neurological Disorder titled ‘Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course.’ 

      People in the study being treated with disease-modifying drugs had significantly lower levels than those not on any active treatment, but what was somewhat unexpected was that even in those not being treated, around 8.1 per cent had IgG levels below the normal level.

      And that’s why we should at least get flu injections.

      Any thought on this research?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2020 All rights reserved.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account